Analyst Signal

AbbVie Inc. (ABBV) is currently trading at $208.84. Based on 29 Wall Street analysts, the average target price is $249.14, implying a 19.3% upside. The consensus recommendation is BUY.

ABBV

AbbVie Inc.

HealthcareOpinion: buy

Opinion Criteria: Based on the consensus of Wall Street analysts. Strong Buy (1.0-1.5), Buy (1.5-2.5), Hold (2.5-3.5), Sell (3.5-4.5), Strong Sell (4.5-5.0).

Price (USD)

$208.84

Avg Target

$249.14

Based on 29 analysts

Analyst Recommendations

Buy (22)Hold (9)Sell (0)

Upside

+19.30%

Market Cap

$369.39B

Financial & Investment Metrics

Next Earnings Date
Apr 29, 2026D-26
P/E Ratio (TTM)88.49
Forward P/E12.96
P/B RatioN/A
Dividend Yield3.31%
Return on Equity (ROE)6225.00%
Operating Margin34.11%
Debt to EquityN/A
Beta (Volatility)0.33
52 Week Range$164.39 - $244.81
LowCurrent: $208.84High

Insider Sentiment Index (Last 6 Months)

Buy vs Sell (Count)

Insider Buys: 10Insider Sells: 3

Whale Trades (C-Level Large Buys)

No major insider buying detected recently.

Frequently Asked Questions

Q. What is the current target price and upside for ABBV?

A. The current target price for AbbVie Inc. is $249.14, which implies a 19.3% upside from the current price of $208.84. This is based on the consensus of 29 Wall Street analysts.

Q. What is the current analyst recommendation for ABBV?

A. Currently, there are 8 Strong Buy, 14 Buy, 9 Hold, 0 Sell, and 0 Strong Sell ratings. The overall consensus is BUY.

Q. Are insiders buying ABBV stock recently?

A. Over the past 6 months, there have been 10 insider buys and 3 insider sells. This can be interpreted as a positive signal.

Other Promising Stocks in Healthcare

ABBV (AbbVie Inc.) Stock Analysis | Analyst Signal